Open Beta
TREN
MetriLume
TREN

US marketsATXI

SEC-sourced researchBeta

ATXI

AVENUE THERAPEUTICS, INC.

Company comparison ↗

Data passport

CIK
0001644963
Exchange
OTC
Business activity
Pharmaceutical Preparations · SIC 2834
Financial inputs
6/6
Filing date
Aug 7, 2026
SEC registry record
Operating company
Last updated: SEC company ticker catalog ↗SEC Financial Statement Data Sets ↗SEC investment company series and class registry ↗

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 0.0000 USD; December 2025: 1,404,000.0000 USD1.4M USD0 USD0December 2024December 2025
ATXI · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20240.0000Mar 30, 2026
December 20251,404,000.0000Mar 30, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 20251,404,000.0000-2,909,000.0000-1,833,000.00002,931,000.00001,099,000.0000Mar 30, 2026
December 20240.0000-11,652,000.0000-9,026,000.00002,672,000.0000816,000.0000Mar 30, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

43/100
Profitability0
Growth—
Balance sheet63
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$1.4MJan 1, 2025 – Dec 31, 2025Mar 30, 202610-K
Previous period revenueRevenues$0Jan 1, 2024 – Dec 31, 2024Mar 30, 202610-K
Net incomeNetIncomeLoss-$2.91MJan 1, 2025 – Dec 31, 2025Mar 30, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$1.83MJan 1, 2025 – Dec 31, 2025Mar 30, 202610-K
Total assetsAssets$2.93MDec 31, 2025Mar 30, 202610-K
Total liabilitiesLiabilities$1.1MDec 31, 2025Mar 30, 202610-K

New filings

Explore methodology ↗